June 12, 2014
by PharmaReviews
0 comments
The U.S. Food and Drug Administration today approved Eloctate, Antihemophilic Factor (Recombinant), Fc fusion protein, for use in adults and children who have Hemophilia A. Eloctate is the first Hemophilia A treatment designed to require less frequent injections when used … Continue reading
June 12, 2014
by PharmaReviews
0 comments
McMaster University researchers may have found a novel way to suppress the devastating side effect of statins, one of the worlds’ most widely used drugs to lower cholesterol and prevent heart disease. The research team – led by Jonathan Schertzer, … Continue reading
June 9, 2014
by PharmaReviews
0 comments
Pfizer has entered a five year collaborative agreement with the Global Medical Excellence Cluster (GMEC) in the UK that will conduct research and develop new medicines aimed at rare diseases. GMEC is comprised of six British universities: Cambridge University, Imperial College … Continue reading